NDC 68071-3725
Aripiprazole 2 mg tablet
On the label: NuCare Pharmaceuticals.Inc.. It's repackaged: NuCare Pharmaceuticals.Inc. rebottles it from Ascend Laboratories, LLC's NDC 67877-430.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Alkem Laboratories Limited | Amaliya Daman, India | Makes it | No problems foundAug 30, 2019 · 6 inspections |
Repackaging site
- NuCare Pharmaceuticals,Inc., Orange, CA, United States · relabels it
Recalls
- Aug 28, 2025 · Class II · Ascend Laboratories, LLC
Superpotent drug
Lots: Lot #: 24144162, Exp. Date 09/2027 - Mar 17, 2023 · Class II · Ascend Laboratories, LLC
Out of specification (OOS) for Spectroscopic Identification test by IR.
Lots: Lot #22143120, Exp. Date: June 2024
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Aripiprazole: every company that makes it
- Form
- tablet, oral
- Strength
- 2 mg
- Approval
- ANDA ANDA207105
- On the market since
- Feb 27, 2019
- Package NDCs
68071-3725-3- Official label
- DailyMed (National Library of Medicine), updated Nov 22, 2024
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?